Vitamin C in Home Parenteral Nutrition: A Need for Monitoring
Résumé
To date, there are no recommendations about screening plasma vitamin C concentration and adjust its supplementation in patients on long-term home parenteral nutrition (HPN). The aim of this study was to evaluate vitamin C status and determine if a commercial multivitamin preparation (CMVP) containing 125 mg of vitamin C is sufficient in stable patients on HPN. All clinically stable patients receiving HPN or an intravenous fluid infusion at least two times per week for at least 6 months, hospitalized for nutritional assessment, were retrospectively included, for a total of 186 patients. We found that 29% of the patients had vitamin C insufficiency (i.e., \textless25 µmol/L). In univariate analysis, C-reactive protein (CRP) (p = 0.002) and intake of only 125 mg of vitamin C (p = 0.001) were negatively associated with vitamin C levels, and duration of follow-up in our referral center (p = 0.009) was positively associated with vitamin C levels. In multivariate analysis, only CRP (p = 0.001) and intake of 125 mg of vitamin C (p \textless 0.0001) were independently associated with low plasma vitamin C concentration. Patients receiving only CMVP with a low plasma vitamin C level significantly received personal compounded HPN (p = 0.008) and presented an inflammatory syndrome (p = 0.002). Vitamin C insufficiency is frequent in individuals undergoing home parenteral nutrition; therefore, there is a need to monitor plasma vitamin C levels, especially in patients on HPN with an inflammatory syndrome and only on CMVP.
Mots clés
vitamin C
Baxter
B Braun
Coloplast
Fresenius Kabi
Nutricia
Nestlé Clinical Nutrition
Shire. C.C. received lecture fees from Aguettant
commercial multivitamin preparation
Elivie
Janssen-Cilag
Mayoly Spindler
and MSD. T.C. none. E.B. none. C.P. received
LVL Medical and Nutricia.
fees from Nestlé Health Science France and Shire. C.B. received lecture fess from
and Nestlé Health Science France. S.A. received lecture
home parenteral nutrition
lecture fees from Takeda and Geistlich Pharma. D.B. received lecture fees from
Shire
Zealand. M.L. received lecture fees from Shire
Theradial
Takeda
Abbvie
Linde Homecare France
Experf Rhone Alpes